Market Brief
North Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief
North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity
Released Tuesday, October 27, 2020
North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity. Major firms such as Merck, Eli Lilly, Pfizer and Grifols are either planting or expanding their manufacturing roots in the state. North Carolina's attraction can be attributed to its skilled workforce, state/local incentives, and proximity to other pharma/biotech firms.
Industrial Info is tracking 95 active capital projects worth more than $5 billion in North Carolina. Click here for the list of projects and see map below.
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Learn MoreRelated Articles
-
Africa's Fertilizer Demand Sparks $5.8 Billion of ProjectsApril 28, 2021
-
Poland's PGE Plans $7 Billion Renewable Energy PushApril 28, 2021
-
Industrial Construction Activity Up 37% So Far in 2021April 26, 2021
Industrial Project Opportunity Database and Project Leads
Get access to verified capital and maintenance project leads to power your growth.
Learn MoreIndustry Intel
-
2026 Regional Chemical Processing OutlookOn-Demand Podcast / Mar. 2, 2026
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025